Early research (Phase 1)Looking for participantsNCT04485013What this trial is testingTTX-080 HLA-G Antagonist in Subjects With Advanced CancersWho this might be right forCancer Tizona Therapeutics, Inc 240
Early research (Phase 1)Looking for participantsNCT06586957What this trial is testingA Study With NKT3964 for Adults With Advanced/Metastatic Solid TumorsWho this might be right forSolid TumorAdvanced Solid TumorSolid Tumor, Adult+25 more NiKang Therapeutics, Inc. 150
Testing effectiveness (Phase 2)Looking for participantsNCT04585750What this trial is testingThe Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)Who this might be right forAdvanced Solid TumorAdvanced Malignant NeoplasmMetastatic Cancer+27 more PMV Pharmaceuticals, Inc 300
Early research (Phase 1)Looking for participantsNCT04389632What this trial is testingSigvotatug Vedotin in Advanced Solid TumorsWho this might be right forCarcinoma, Non-Small Cell LungSquamous Cell Carcinoma of Head and NeckHER2 Negative Breast Neoplasms+9 more Seagen, a wholly owned subsidiary of Pfizer 1,006
Not applicableUnknownNCT05230186What this trial is testingA Tissue Collection Study in Patients Who Respond to Immune Checkpoint Inhibitors to Identify Targets of Tumor-Reactive T Cells.Who this might be right forSolid Tumor, Adult TScan Therapeutics, Inc. 200
Large-scale testing (Phase 3)UnknownNCT03332069What this trial is testingModulated Electro-Hyperthermia Plus Chemo-radiation for Locally Advanced Cervical Cancer Patients in South AfricaWho this might be right forCervical Cancer Jeffrey Kotzen 236
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06976021What this trial is testingImmune PET and Proteomics for the Assessment of Response to Spatially Fractionated or Palliative Radiotherapy With or Without ImmunotherapyWho this might be right forTriple Negative Breast CancerUterine Cervical CancerUterine Corpus Cancer+2 more Maria Sklodowska-Curie National Research Institute of Oncology 60
Early research (Phase 1)Active Not RecruitingNCT04432857What this trial is testingAN0025 and Pembrolizumab Combination in Advanced Solid TumorsWho this might be right forTriple-negative Breast CancerNSCLC, Squamous or Non-SquamousUrothelial Carcinoma of the Bladder+2 more Adlai Nortye Biopharma Co., Ltd. 63
Early research (Phase 1)Ended earlyNCT03746431What this trial is testing[225Ac]-FPI-1434 InjectionWho this might be right forAdvanced Solid TumoursEndometrial CancerCervical Cancer+7 more Fusion Pharmaceuticals Inc. 78
Testing effectiveness (Phase 2)Looking for participantsNCT05086692What this trial is testingA Beta-only IL-2 ImmunoTherapY StudyWho this might be right forAdvanced Solid TumorUnresectable Solid TumorClear Cell Renal Cell Carcinoma+34 more Medicenna Therapeutics, Inc. 115
Early research (Phase 1)Study completedNCT05712889What this trial is testingPhase 1 Dose Escalation Study for VIP236 in Patients With Advanced CancerWho this might be right forNeoplasms Vincerx Pharma, Inc. 29
Early research (Phase 1)Ended earlyNCT05194072What this trial is testingFelmetatug Vedotin/SGN-B7H4V in Advanced Solid TumorsWho this might be right forOvarian NeoplasmsPeritoneal NeoplasmsFallopian Tube Neoplasms+8 more Seagen, a wholly owned subsidiary of Pfizer 250
Early research (Phase 1)Looking for participantsNCT05683418What this trial is testingEvaluate the Safety and Tolerability of TOS-358 in Adults With HR+ Breast Cancer and Other Select Solid TumorsWho this might be right forSquamous Cell Carcinoma of Head and NeckEndometrial CancerHR+/HER2-negative Breast Cancer+1 more Totus Medicines 241
Not applicableLooking for participantsNCT06196190What this trial is testingPrognostic Value of Conization and Negative HPV After Conization in AIS and Early Stage Cervical CancerWho this might be right forCervix CancerHPV-Related Malignancy Rambam Health Care Campus 200
Not applicableUnknownNCT05099978What this trial is testingAsian Multicenter Prospective Study of ctDNA SequencingWho this might be right forCervical CancerOvarian Clear Cell CarcinomaNasopharyngeal Carcinoma+3 more National Cancer Center, Japan 506
Early research (Phase 1)Looking for participantsNCT05107674What this trial is testingNX-1607 in Adults With Advanced MalignanciesWho this might be right forOvarian Cancer, EpithelialGastric CancerGastroEsophageal Junction (GEJ) Cancer+11 more Nurix Therapeutics, Inc. 345
Early research (Phase 1)Active Not RecruitingNCT04491942What this trial is testingTesting the Addition of an Anti-cancer Drug, BAY 1895344, to the Usual Chemotherapy Treatment (Cisplatin, or Cisplatin and Gemcitabine) for Advanced Solid Tumors With Emphasis on Urothelial CancerWho this might be right forAdvanced Bile Duct CarcinomaAdvanced Breast CarcinomaAdvanced Cervical Carcinoma+31 more National Cancer Institute (NCI) 74
Early research (Phase 1)Study completedNCT03752398What this trial is testingXmAb®23104 in Subjects With Selected Advanced Solid Tumors (DUET-3)Who this might be right forMelanoma (Excluding Uveal Melanoma)Cervical CarcinomaPancreatic Carcinoma+13 more Xencor, Inc. 198
Large-scale testing (Phase 3)Ended earlyNCT01072136What this trial is testingEmpiric Therapy of Mucopurulent Cervicitis (MPC)Who this might be right forVaginitis BacterialCervicitis National Institute of Allergy and Infectious Diseases (NIAID) 87
Testing effectiveness (Phase 2)Looking for participantsNCT06993844What this trial is testingPhase 1/2 Study of ETX-636 in Participants With Advanced Solid TumorsWho this might be right forAdvanced Solid TumorsAdvanced Breast Cancer Ensem Therapeutics 233